Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications

Abstract

Oxidative stress is characterized by the deregulation of the redox state in the cells, which plays a role in the initiation of various types of cancers. The activity of galectin-1 (Gal-1) depends on the cell redox state and the redox state of the microenvironment. Gal-1 expression has been related to many different tumor types, as it plays important roles in several processes involved in cancer progression, such as apoptosis, cell migration, adhesion, and immune response. The erythroid-2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) signaling pathway is a crucial mechanism involved in both cell survival and cell defense against oxidative stress. In this review, we delve into the cellular and molecular roles played by Gal-1 in the context of oxidative stress onset in cancer cells, particularly focusing on its involvement in activating the Nrf2/Keap1 signaling pathway. The emerging evidence concerning the anti-apoptotic effect of Gal-1, together with its ability to sustain the activation of the Nrf2 pathway in counteracting oxidative stress, supports the role of Gal-1 in the promotion of tumor cells proliferation, immuno-suppression, and anti-tumor drug resistance, thus highlighting that the inhibition of Gal-1 emerges as a potential strategy for the restraint and regression of tumor progression. Overall, a deeper understanding of the multi-functionality and disease-specific expression profiling of Gal-1 will be crucial for the design and development of novel Gal-1 inhibitors as anticancer agents. Excitingly, although it is still understudied, the ever-growing knowledge of the sophisticated interplay between Gal-1 and Nrf2/Keap1 will enable researchers to gain valuable insights into the underlying causes of carcinogenesis and metastasis.

Keywords

Galectin-1 / Nrf2 / oxidative stress / cancer drug resistance

References

[1] Hassanpour SH.Review of cancer from perspective of molecular.J Cancer Res Pract2017;4:127-9

[2] Chio IIC,Ponz-Sarvise M.NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer.Cell2016;166:963-76 PMCID:PMC5234705

[3] Malhotra D,Singh A.Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis.Nucleic Acids Res2010;38:5718-34 PMCID:PMC2943601

[4] Tonelli C,Tuveson DA.Transcriptional regulation by Nrf2.Antioxid Redox Signal2018;29:1727-45 PMCID:PMC6208165

[5] Abdul-Muneer PM.Nrf2 as a potential therapeutic target for traumatic brain injury.J Integr Neurosci2023;22:81

[6] Lu J,Cao J,Dong Y.A novel and compact review on the role of oxidative stress in female reproduction.Reprod Biol Endocrinol2018;16:80 PMCID:PMC6102891

[7] Nezu M,Yu L.Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes.Sci Signal2017;10:eaam5711

[8] Zdanov S,Debacq-Chainiaux F.p53 and ATF-2 partly mediate the overexpression of COX-2 in H₂O₂-induced premature senescence of human fibroblasts.Biogerontology2009;10:291-8

[9] Fuertes-Agudo M,Cucarella C,Casado M.Advances in understanding the role of NRF2 in liver pathophysiology and its relationship with hepatic-specific cyclooxygenase-2 expression.Antioxidants2023;12:1491 PMCID:PMC10451723

[10] Dinkova-Kostova AT.The emerging role of Nrf2 in mitochondrial function.Free Radic Biol Med2015;88:179-88 PMCID:PMC4726722

[11] Ma Q.Role of nrf2 in oxidative stress and toxicity.Annu Rev Pharmacol Toxicol2013;53:401-26 PMCID:PMC4680839

[12] Chen B,Chen Y.The role of Nrf2 in oxidative stress-induced endothelial injuries.J Endocrinol2015;225:R83-99

[13] Negi CK.Nrf2, a novel molecular target to reduce type 1 diabetes associated secondary complications: the basic considerations.Eur J Pharmacol2019;843:12-26

[14] Khassafi N,Mirzaei H.Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: mechanisms of action and therapeutic implications.Exp Neurol2024;373:114655

[15] Vinnai JR,Thompson GJ.The association between oxidative stress-induced galectins and differentiation of human promyelocytic HL-60 cells.Exp Cell Res2017;355:113-23

[16] Kasai K.Galectins: a family of animal lectins that decipher glycocodes.J Biochem1996;119:1-8

[17] Levi G.Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of electrophorus electricus.J Biol Chem1981;256:5735-40

[18] Coppin L,Ait Yahya E.Galectin-3 modulates epithelial cell adaptation to stress at the ER-mitochondria interface.Cell Death Dis2020;11:360 PMCID:PMC7217954

[19] Guardia CM,Trujillo M.Structural basis of redox-dependent modulation of galectin-1 dynamics and function.Glycobiology2014;24:428-41 PMCID:PMC3976282

[20] Liu FT.Galectins: regulators of acute and chronic inflammation.Ann N Y Acad Sci2010;1183:158-82

[21] Di Lella S,Cerliani JP.When galectins recognize glycans: from biochemistry to physiology and back again.Biochemistry2011;50:7842-57 PMCID:PMC3429939

[22] Camby I,Lefranc F.Galectin-1: a small protein with major functions.Glycobiology2006;16:137R-57R

[23] Chetry M,Hu X.The role of galectins in tumor progression, treatment and prognosis of gynecological cancers.J Cancer2018;9:4742-55 PMCID:PMC6299382

[24] Zhu J,Zhang H,Sun H.Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway.Am J Transl Res2019;11:3862-78 PMCID:PMC6614631

[25] Barondes SH,Cooper DN.Galectins: a family of animal beta-galactoside-binding lectins.Cell1994;76:597-8

[26] Cho M.Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization.J Biol Chem1995;270:5198-206

[27] Tracey B,Abbott W,Green B.Subunit molecular mass assignment of 14,654 Da to the soluble beta-galactoside-binding lectin from bovine heart muscle and demonstration of intramolecular disulfide bonding associated with oxidative inactivation.J Biol Chem1992;267:10342-7

[28] López-Lucendo MF,André S.Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding.J Mol Biol2004;343:957-70

[29] Ge XN,Greenberg YG.Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1.Proc Natl Acad Sci U S A2016;113:E4837-46 PMCID:PMC4995939

[30] Rabinovich GA.Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation.Nat Rev Immunol2009;9:338-52

[31] Perillo NL,Baum LG.Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death.J Mol Med1998;76:402-12

[32] Hafer-Macko C,Seilhamer JJ.Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.Glycoconj J1996;13:591-7

[33] Rudjord-Levann AM,Hafkenscheid L.Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1.iScience2023;26:106984 PMCID:PMC10391608

[34] Wasano K,Yamamoto T.Immunohistochemical localization of 14 kDa beta-galactoside-binding lectin in various organs of rat.Cell Tissue Res1990;259:43-9

[35] Akazawa C,Sango K,Kohsaka S.Distribution of the galectin-1 mRNA in the rat nervous system: its transient upregulation in rat facial motor neurons after facial nerve axotomy.Neuroscience2004;125:171-8

[36] Almkvist J.Galectins as inflammatory mediators.Glycoconj J2002;19:575-81

[37] Rabinovich GA,Hershkoviz R,Kasai KI.Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1.Immunology1999;97:100-6 PMCID:PMC2326819

[38] de Freitas Zanon C, Sonehara NM, Girol AP, Gil CD, Oliani SM. Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation.Mol Vis2015;21:1036-50 PMCID:PMC4556161

[39] Orozco CA,Guerrero PE.Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.Proc Natl Acad Sci U S A2018;115:E3769-78 PMCID:PMC5910865

[40] Leung Z,Tey SK.Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.J Exp Clin Cancer Res2019;38:423 PMCID:PMC6805403

[41] Kopitz J,Burchert M,Gabius HJ.Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture.J Biol Chem1998;273:11205-11

[42] Tinari N,Huflejt ME,Iacobelli S.Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation.Int J Cancer2001;91:167-72

[43] Thijssen VL,Shoji H.Tumor cells secrete galectin-1 to enhance endothelial cell activity.Cancer Res2010;70:6216-24

[44] Jung TY,Ryu HH.Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.J Neurosurg2008;109:273-84

[45] Wu MH,Cheng HW.Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.Mol Cancer Res2009;7:311-8

[46] Camby I,Lefranc F.Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases.J Neuropathol Exp Neurol2002;61:585-96

[47] Wu MH,Hong TM,Lin YT.Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex.Angiogenesis2014;17:839-49

[48] Patterson RJ,Wang JL.Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus.Glycoconj J2002;19:499-506

[49] Vyakarnam A,Wang JL.Evidence for a role for galectin-1 in pre-mRNA splicing.Mol Cell Biol1997;17:4730-7 PMCID:PMC232325

[50] Schwarz FP,Bianchet MA,Vasta GR.Thermodynamics of bovine spleen galectin-1 binding to disaccharides: correlation with structure and its effect on oligomerization at the denaturation temperature.Biochemistry1998;37:5867-77

[51] van der Leij J,Blokzijl T.Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response.J Pathol2004;204:511-8

[52] Femel J,Herre M.Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.Cancer Immunol Immunother2022;71:2029-40 PMCID:PMC9293851

[53] Dalotto-Moreno T,Cerliani JP.Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.Cancer Res2013;73:1107-17

[54] Nambiar DK,Cao H.Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment.Cancer Res2023;83:3205-19 PMCID:PMC10592379

[55] Mileo AM.Polyphenols as modulator of oxidative stress in cancer disease: new therapeutic strategies.Oxid Med Cell Longev2016;2016:6475624 PMCID:PMC4663347

[56] Gorrini C,Mak TW.Modulation of oxidative stress as an anticancer strategy.Nat Rev Drug Discov2013;12:931-47

[57] DeNicola GM,Humpton TJ.Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.Nature2011;475:106-9 PMCID:PMC3404470

[58] Ramos-Gomez M,Dolan PM.Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.Proc Natl Acad Sci U S A2001;98:3410-5 PMCID:PMC30667

[59] Hayes JD.The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer.Mol Cell2006;21:732-4

[60] Tossetta G,Montanari E,Goteri G.Role of NRF2 in ovarian cancer.Antioxidants2022;11:663 PMCID:PMC9027335

[61] Staurengo-Ferrari L,Hohmann MSN.Contribution of Nrf2 modulation to the mechanism of action of analgesic and anti-inflammatory drugs in pre-clinical and clinical stages.Front Pharmacol2018;9:1536 PMCID:PMC6337248

[62] Bao L,Dodson M.ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.Mol Carcinog2017;56:1543-53 PMCID:PMC5509336

[63] Campagna R,Giorgini S.Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance.Hum Cell2023;36:1108-19

[64] Campagna R,Salvolini E.Paraoxonase-2 silencing enhances sensitivity of A375 melanoma cells to treatment with cisplatin.Antioxidants2020;9:1238 PMCID:PMC7762224

[65] Campagna R,Pozzi V.Role played by paraoxonase-2 enzyme in cell viability, proliferation and sensitivity to chemotherapy of oral squamous cell carcinoma cell lines.Int J Mol Sci2022;24:338 PMCID:PMC9820498

[66] Fumarola S,Sartini D.Bladder cancer chemosensitivity is affected by paraoxonase-2 expression.Antioxidants2020;9:175 PMCID:PMC7070528

[67] Nagarajan A,Sun L.Paraoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1-mediated glucose transport.Mol Cell2017;67:685-701.e6 PMCID:PMC5567863

[68] Tseng JH,Chen PC.Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.Oncotarget2017;8:14666-79 PMCID:PMC5362434

[69] Barrera G,Grattarola M,Muzio G.Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role.Antioxidants2021;10:510 PMCID:PMC8064392

[70] Sferrazzo G,Barone E.Heme oxygenase-1 in central nervous system malignancies.J Clin Med2020;9:1562 PMCID:PMC7290325

[71] Niture SK.Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.Free Radic Biol Med2013;57:119-31 PMCID:PMC3606082

[72] Saha S,Panieri E,Saso L.An overview of Nrf2 signaling pathway and its role in inflammation.Molecules2020;25:5474 PMCID:PMC7700122

[73] Kansanen E,Levonen AL.Regulation of Nrf2-dependent gene expression by 15-deoxy-Δ^12,14-prostaglandin J₂.Free Radic Biol Med2009;47:1310-7

[74] He F,Wen T.NRF2, a transcription factor for stress response and beyond.Int J Mol Sci2020;21:4777 PMCID:PMC7369905

[75] Itoh K,Katoh Y.Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.Genes Dev1999;13:76-86 PMCID:PMC316370

[76] Panieri E.Potential applications of NRF2 inhibitors in cancer therapy.Oxid Med Cell Longev2019;2019:8592348 PMCID:PMC6487091

[77] Sova M.Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review.Drug Des Devel Ther2018;12:3181-97 PMCID:PMC6161735

[78] Dinkova-Kostova AT,Canning P.Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.Arch Biochem Biophys2017;617:84-93 PMCID:PMC5339396

[79] Taguchi K,Yamamoto M.Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.Genes Cells2011;16:123-40

[80] Kansanen E,Leinonen H.The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer.Redox Biol2013;1:45-9 PMCID:PMC3757665

[81] Li W,Liu T.Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif.Biochim Biophys Acta2008;1783:1847-56 PMCID:PMC2570698

[82] Itoh K,Takahashi S.An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.Biochem Biophys Res Commun1997;236:313-22

[83] Bayo Jimenez MT,Hahad O.Protective actions of nuclear factor erythroid 2-related factor 2 (NRF2) and downstream pathways against environmental stressors.Free Radic Biol Med2022;187:72-91

[84] Cuadrado A,Hassan A.Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach.Pharmacol Rev2018;70:348-83

[85] Kaspar JW,Jaiswal AK.Nrf2:INrf2 (Keap1) signaling in oxidative stress.Free Radic Biol Med2009;47:1304-9 PMCID:PMC2763938

[86] Shaw P.Nrf2-ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms.J Cell Physiol2020;235:3119-30

[87] Stefanson AL.Dietary regulation of Keap1/Nrf2/ARE pathway: focus on plant-derived compounds and trace minerals.Nutrients2014;6:3777-801 PMCID:PMC4179188

[88] Choi AM.Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury.Am J Respir Cell Mol Biol1996;15:9-19

[89] Sun J,Zenke Y,Groudine M.Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network.Proc Natl Acad Sci U S A2004;101:1461-6 PMCID:PMC341742

[90] Kaspar JW.Antioxidant-induced phosphorylation of tyrosine 486 leads to rapid nuclear export of Bach1 that allows Nrf2 to bind to the antioxidant response element and activate defensive gene expression.J Biol Chem2010;285:153-62 PMCID:PMC2804160

[91] Zenke-Kawasaki Y,Katoh Y.Heme induces ubiquitination and degradation of the transcription factor Bach1.Mol Cell Biol2007;27:6962-71 PMCID:PMC2099246

[92] Lignitto L,Homer H.Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1.Cell2019;178:316-29.e18 PMCID:PMC6625921

[93] Wiel C,Ibrahim MX.BACH1 stabilization by antioxidants stimulates lung cancer metastasis.Cell2019;178:330-45.e22

[94] Gall Trošelj K,Jaganjac M.Oxidative stress and cancer heterogeneity orchestrate NRF2 roles relevant for therapy response.Molecules2022;27:1468 PMCID:PMC8912061

[95] Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer.Cancer Cell2018;34:21-43 PMCID:PMC6039250

[96] Iida K,Kumagai Y.Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.Cancer Res2004;64:6424-31

[97] Mitsuishi Y,Kawatani Y.Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.Cancer Cell2012;22:66-79

[98] Sporn MB.NRF2 and cancer: the good, the bad and the importance of context.Nat Rev Cancer2012;12:564-71 PMCID:PMC3836441

[99] Rubinstein N,Zwirner NW.Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege.Cancer Cell2004;5:241-51

[100] Liu FT.Galectins as modulators of tumour progression.Nat Rev Cancer2005;5:29-41

[101] Tang D,Xue X.High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer.Int J Cancer2012;130:2337-48

[102] Tsai YT,Yu JH.A DNA aptamer targeting galectin-1 as a novel immunotherapeutic strategy for lung cancer.Mol Ther Nucleic Acids2019;18:991-8 PMCID:PMC6889073

[103] Perillo NL,Seilhamer JJ.Apoptosis of T cells mediated by galectin-1.Nature1995;378:736-9

[104] Górniak P,Ługowska I.BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells.Mol Oncol2020;14:1817-32 PMCID:PMC7400781

[105] You Y,Dai HS.MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.Oncotarget2016;7:57099-116 PMCID:PMC5302976

[106] Soldati R,Zenclussen AC.Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments.Int J Cancer2012;131:1131-41

[107] Huang EY,Chen YM.A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells.Cell Death Dis2012;3:e251 PMCID:PMC3270263

[108] Chung LY,Sun GH.Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.Clin Cancer Res2012;18:4037-47

[109] Carabias P,Bacigalupo ML.Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.Cell Death Dis2022;13:79 PMCID:PMC8786848

[110] Bacigalupo ML,Espelt MV.Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.J Cell Physiol2015;230:1298-309

[111] Nam K,Oh S.Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.Oncotarget2017;8:35804-23 PMCID:PMC5482619

[112] Wang F,Gu Y,Ge X.Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway.Oncotarget2017;8:25097-106 PMCID:PMC5421912

[113] Le Mercier M,Haibe-Kains B.Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.J Neuropathol Exp Neurol2008;67:456-69

[114] Ito K,Cutler S.Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.Angiogenesis2011;14:293-307 PMCID:PMC3155035

[115] Pizzino G,Cucinotta M.Oxidative stress: harms and benefits for human health.Oxid Med Cell Longev2017;2017:8416763 PMCID:PMC5551541

[116] Raffaghello L,Safdie FM.Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.Proc Natl Acad Sci U S A2008;105:8215-20 PMCID:PMC2448817

[117] Pateras IS,Gianniou DD.Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming.J Transl Med2023;21:169 PMCID:PMC9983166

[118] Hogas S,Branisteanu D.Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.Arch Med Sci2017;13:897-913 PMCID:PMC5507105

[119] Reuter S,Chaturvedi MM.Oxidative stress, inflammation, and cancer: how are they linked?.Free Radic Biol Med2010;49:1603-16 PMCID:PMC2990475

[120] Tazhitdinova R.The emerging role of galectins and O-GlcNAc homeostasis in processes of cellular differentiation.Cells2020;9:1792 PMCID:PMC7465113

[121] Matarrese P,Mormone E.Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission.J Biol Chem2005;280:6969-85

[122] Thijssen VL,Brandwijk RJ.Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.Proc Natl Acad Sci U S A2006;103:15975-80 PMCID:PMC1635112

[123] Wada J.Galectins, galactoside-binding mammalian lectins: clinical application of multi-functional proteins.Acta Med Okayama2001;55:11-7

[124] Weng IC,Lo TH.Cytosolic galectin-3 and -8 regulate antibacterial autophagy through differential recognition of host glycans on damaged phagosomes.Glycobiology2018;28:392-405

[125] Karlsson A,Leffler H.Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils.Blood1998;91:3430-8

[126] Wolf Y,Kuchroo VK.TIM3 comes of age as an inhibitory receptor.Nat Rev Immunol2020;20:173-85 PMCID:PMC7327798

[127] Solinas C,Bron D,Sangiolo D.Significance of TIM3 expression in cancer: from biology to the clinic.Semin Oncol2019;46:372-9

[128] Rezaei M,Ghezelbash B.TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines.Front Immunol2023;14:1267578 PMCID:PMC10667689

[129] Shen L,Chen Z,Zhang C.Pre-treatment with galectin-1 attenuates lipopolysaccharide-induced myocarditis by regulating the Nrf2 pathway.Eur J Histochem2023;67:3816 PMCID:PMC10773196

[130] Liu HB,Zhang XD,Li JY.The neuroprotective effects of Galectin-1 on Parkinson’s disease via regulation of Nrf2 expression.Eur Rev Med Pharmacol Sci2022;26:623-36

[131] Park SY,Park SY.Role of AMPK in regulation of oxaliplatin-resistant human colorectal cancer.Biomedicines2022;10:2690 PMCID:PMC9687437

[132] Petsouki E,Heiss EH.AMPK and NRF2: interactive players in the same team for cellular homeostasis?.Free Radic Biol Med2022;190:75-93

[133] Huang XT,Zhou Y.Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway in mice.Free Radic Biol Med2020;146:222-33

[134] Wells V.Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator.Cell1991;64:91-7

[135] Astorgues-Xerri L,Tijeras-Raballand A.OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.Eur J Cancer2014;50:2463-77

[136] Zucchetti M,Frapolli R.Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.Cancer Chemother Pharmacol2013;72:879-87

[137] Dings RP,Miller MC.Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.J Pharmacol Exp Ther2013;344:589-99 PMCID:PMC3583509

[138] Croci DO,Rubinstein N.Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma.J Exp Med2012;209:1985-2000 PMCID:PMC3478924